Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2023-01-07 21:26:51]
5 Years H Index
2
Impact Factor (IF)
0
5 Years IF
0.01
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
2017 0 0.55 0.07 0 60 60 8 4 4 0 0 4 100 4 0.07 0.21
2018 0.05 0.57 0.04 0.05 29 89 2 4 8 60 3 60 3 4 100 0 0.24
2019 0 0.6 0 0 17 106 0 8 89 89 0 0 0.24
2020 0.07 0.73 0.04 0.03 6 112 0 4 12 46 3 106 3 2 50 0 0.34
IF: Two years Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for all series in RePEc in year y
CIF: Cumulative impact factor
IF5: Five years Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12017Erythrocyte as a Therapeutic Target. (2017). Herdade, Ana Silva ; Saldanha, Carlota. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:2:y:2017:i:3:p:64-66.

Full description at Econpapers || Download paper

2
22018So, Antidepressant Drugs have Serious Adverse Effects, but what are the Alternatives?. (2018). Hendawy, Amin Omar ; Ali, Amira Mohammed. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:4:y:2018:i:3:p:58-69.

Full description at Econpapers || Download paper

2
32017Mechanistic Aspects of Autism Involving Electron Transfer, Reactive Oxygen Species, Oxidative Stress, Pollutants, Antioxidants, Cell Signaling and Genes. (2017). Somanathan, Ratnasamy ; Kovacic, Peter. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:1:y:2017:i:3:p:40-47.

Full description at Econpapers || Download paper

2
42017Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity. (2017). Martins, Ian James. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:1:y:2017:i:3:p:38-39.

Full description at Econpapers || Download paper

1
52017Sepsis Needs Follow-Up Studies in Intensive Care Units- Another Avenue for Translational Research. (2017). Messias, Antnio ; Saldanha, Carlota. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:1:y:2017:i:1:p:12-14.

Full description at Econpapers || Download paper

1
62017Mechanisms of AMR: Mdr Genes and Antibiotics Decoys Retard the New Antibiotic Discovery against Superbugs. (2017). Chakraborty, Asit Kumar. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:2:y:2017:i:1:p:1-5.

Full description at Econpapers || Download paper

1
72018Erythrocyte Acetylcholinesterase is a Signaling Receptor. (2018). Herdade, Ana Silva ; Saldanha, Carlota. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:3:y:2018:i:4:p:77-80.

Full description at Econpapers || Download paper

1
82017Different Disciplines in the Field of Suicide Study. (2017). Yarla, Nagendra Sastry ; Lu, Ting-Ren ; Caox, Shan. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:1:y:2017:i:4:p:58-59.

Full description at Econpapers || Download paper

1
92017Phenolic Antioxidants as Drugs for Alzheimer’s Disease: Oxidative Stress and Selectivity. (2017). Weston, Wil ; Kovacic, Peter. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:3:y:2017:i:2:p:24-27.

Full description at Econpapers || Download paper

1
102017Phenolic Antioxidants as Drugs for Alzheimer’s Disease: Oxidative Stress and Selectivity. (2017). Kovacic, Peter. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:2:y:2017:i:5:p:95-97.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12018So, Antidepressant Drugs have Serious Adverse Effects, but what are the Alternatives?. (2018). Hendawy, Amin Omar ; Ali, Amira Mohammed. In: Novel Approaches in Drug Designing & Development. RePEc:adp:jnapdd:v:4:y:2018:i:3:p:58-69.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor:
YearTitle
Recent citations
Recent citations received in 2018

YearCiting document